Articles with public access mandates - Graham BallLearn more
Not available anywhere: 5
Guidelines and considerations for conducting experiments using tissue microarrays
M Ilyas, H Grabsch, IO Ellis, C Womack, R Brown, D Berney, D Fennell, ...
Histopathology 62 (6), 827-839, 2013
Mandates: Cancer Research UK
Prognostic stratification of oestrogen receptor‐positive HER 2‐negative lymph node‐negative class of breast cancer
EA Rakha, D Agarwal, AR Green, I Ashankyty, IO Ellis, G Ball, ...
Histopathology 70 (4), 622-631, 2017
Mandates: UK Medical Research Council
Relationship between preparation of cells for therapy and cell quality using artificial neural network analysis
GK Dhondalay, K Lawrence, S Ward, G Ball, M Hoare
Artificial intelligence in medicine 62 (2), 119-127, 2014
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Engineering …
Advances in drug discovery based on genomics, proteomics and bioinformatics in malaria
S Aggarwal, A Karmakar, S Krishnakumar, U Paul, A Singh, N Banerjee, ...
Current Topics in Medicinal Chemistry 23 (7), 551-578, 2023
Mandates: Indian Council of Agricultural Research
Comprehensive proteomic analysis reveals distinct functional modules associated with skull base and supratentorial meningiomas and perturbations in collagen pathway components
S Mukherjee, D Biswas, S Epari, P Shetty, A Moiyadi, GR Ball, ...
Journal of Proteomics 246, 104303, 2021
Mandates: Department of Biotechnology, India
Available somewhere: 54
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting
RW McGilvray, RA Eagle, NFS Watson, A Al-Attar, G Ball, I Jafferji, ...
Clinical Cancer Research 15 (22), 6993-7002, 2009
Mandates: Cancer Research UK
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
EA Rakha, D Soria, AR Green, C Lemetre, DG Powe, CC Nolan, ...
British journal of cancer 110 (7), 1688-1697, 2014
Mandates: UK Medical Research Council
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
AR Green, MA Aleskandarany, D Agarwal, S Elsheikh, CC Nolan, ...
British journal of cancer 114 (8), 917-928, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
TMA Abdel-Fatah, R Russell, N Albarakati, DJ Maloney, D Dorjsuren, ...
Molecular oncology 8 (7), 1326-1338, 2014
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis
TMA Abdel-Fatah, D Agarwal, DX Liu, R Russell, OM Rueda, K Liu, B Xu, ...
The Lancet Oncology 17 (7), 1004-1018, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ
AJ Maxwell, K Clements, B Hilton, DJ Dodwell, A Evans, O Kearins, ...
European Journal of Surgical Oncology 44 (4), 429-435, 2018
Mandates: British Heart Foundation, Cancer Research UK, UK Medical Research Council
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
N Albarakati, TMA Abdel-Fatah, R Doherty, R Russell, D Agarwal, ...
Molecular oncology 9 (1), 204-217, 2015
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
AM Thompson, K Clements, S Cheung, SE Pinder, G Lawrence, E Sawyer, ...
European Journal of Cancer 101, 210-219, 2018
Mandates: Breast Cancer Now, UK, Cancer Research UK, UK Medical Research Council …
Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid
B Vafadar-Isfahani, G Ball, C Coveney, C Lemetre, D Boocock, L Minthon, ...
Journal of Alzheimer's Disease 28 (3), 625-636, 2012
Mandates: Swedish Research Council
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy
R Abbotts, R Jewell, J Nsengimana, DJ Maloney, A Simeonov, ...
Oncotarget 5 (10), 3273, 2014
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype
HO Habashy, DG Powe, E Glaab, G Ball, I Spiteri, N Krasnogor, ...
Breast cancer research and treatment 128, 315-326, 2011
Mandates: Cancer Research UK
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
AR Green, DG Powe, EA Rakha, D Soria, C Lemetre, CC Nolan, ...
British journal of cancer 109 (7), 1886-1894, 2013
Mandates: UK Medical Research Council
Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction
G Furini, N Schroeder, L Huang, D Boocock, A Scarpellini, C Coveney, ...
Journal of the American Society of Nephrology 29 (3), 880-905, 2018
Mandates: Wellcome Trust
KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach
WJF Green, G Ball, G Hulman, C Johnson, G Van Schalwyk, HL Ratan, ...
British journal of cancer 115 (2), 236-242, 2016
Mandates: UK Medical Research Council
RECQL4 helicase has oncogenic potential in sporadic breast cancers
A Arora, D Agarwal, TMA Abdel‐Fatah, H Lu, DL Croteau, P Moseley, ...
The Journal of pathology 238 (4), 495-501, 2016
Mandates: US National Institutes of Health, Cancer Research UK
Publication and funding information is determined automatically by a computer program